UBS AM
SANA icon

UBS AM’s Sana Biotechnology SANA Stock Holding History

UBS AM’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993K Buy
284,472
+52,766
+23% +$170K ﹤0.01% 2343
2026
Q1 		$667K Sell
231,706
-8,708
-4% -$34.3K ﹤0.01% 2470
2025
Q4 		$978K Buy
240,414
+99,767
+71% +$447K ﹤0.01% 2144
2025
Q3 		$499K Buy
+140,647
New +$508K ﹤0.01% 2157
2025
Q2 		– Sell
-284,924
Closed -$479K – 2705
2025
Q1 		$479K Buy
284,924
+5,642
+2% +$15.8K ﹤0.01% 2508
2024
Q4 		$455K Buy
279,282
+25,383
+10% +$75.7K ﹤0.01% 2567
2024
Q3 		$1.06M Buy
253,899
+6,823
+3% +$35.8K ﹤0.01% 2366
2024
Q2 		$1.35M Buy
247,076
+163,729
+196% +$1.3M ﹤0.01% 2214
2024
Q1 		$833K Buy
83,347
+18,064
+28% +$135K ﹤0.01% 2098
2023
Q4 		$266K Buy
65,283
+7,688
+13% +$28.3K ﹤0.01% 2447
2023
Q3 		$223K Buy
57,595
+19,777
+52% +$106K ﹤0.01% 2496
2023
Q2 		$124K Hold
37,818
– – ﹤0.01% 2623
2023
Q1 		$124K Sell
37,818
-14,800
-28% -$59.1K ﹤0.01% 2623
2022
Q4 		$208K Hold
52,618
– – ﹤0.01% 2435
2022
Q3 		$316K Sell
52,618
-19,982
-28% -$144K ﹤0.01% 2483
2022
Q2 		$467K Buy
72,600
+48,000
+195% +$306K ﹤0.01% 2344
2022
Q1 		$203K Hold
24,600
– – ﹤0.01% 2676
2021
Q4 		$381K Buy
+24,600
New +$474K ﹤0.01% 2630

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

UBS AM's SANA Position: Q2 2026 in Review

UBS AM increased its Sana Biotechnology (SANA) stake by 23% in Q2 2026, buying an estimated $170K and bringing the position to 284,472 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

UBS AM first reported a position in SANA in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.35M in Q2 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • UBS AM held 284,472 shares of Sana Biotechnology worth $993K as of Q2 2026.
  • UBS AM bought 52,766 Sana Biotechnology shares in Q2 2026, an estimated $170K.
  • Sana Biotechnology made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2343 holding.
  • UBS AM first reported a position in Sana Biotechnology in Q4 2021 and has held it in 18 quarters since.
  • UBS AM's Sana Biotechnology position peaked at $1.35M in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.